Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAN-CHA: MPL-001 for Chronic Headaches in Adolescents
NCT05337033Phase 2Recruiting
- Sponsor
- University of Manitoba
- Start
- Oct 2024
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of MPL-001 in chronic migraine, sponsored by University of Manitoba. Started Oct 2024; status: recruiting.
02
Drugs
MPL-001
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT05337033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05337033.